The REPROCELL Blog
Research, reports, and resources
Latest Posts
Explore the crucial role of early genetic variant detection in iPSC cultures for ensuring safe, effective, and regulatory-compliant cell therapies. Learn about risk profiling and REPROCELL’s solutions.
01 August 2025
Subcutaneous Artery Assays Help Us to Understand Blood Pressure Regulation
Explore how subcutaneous artery assays enhance understanding of blood pressure regulation and aid in the development of safer, more effective cardiovascular drugs.
07 July 2025
Able Biott Single-use Bioreactors Enhance the Development of Disease Models and Cell Therapy
Discover how Able Biott single-use bioreactors enhance disease modeling and cell therapy development through scalable, efficient iPSC culture solutions.
03 July 2025
Why mRNA Reprogramming Is the Key to Safer and Faster iPSC Generation?
Discover how mRNA reprogramming enhances the safety, efficiency, and scalability of iPSC generation for therapeutic applications. Explore REPROCELL's innovative technologies and services.
10 June 2025
Featured Posts
REPROCELL’s Stemgent Brings mRNA Reprogramming to the Clinical Sector
Discover how REPROCELL has employed its StemRNA™ 4th Generation Reprogramming Technology to bring the power of mRNA reprogramming to the clinical sector.
How human fresh tissue models are helping RCD405 achieve regulatory approval
Discover how Arcede Pharma recently used human tissue testing to generate preclinical efficacy data for their compound RCD405.
How to isolate PBMCs from whole blood using density gradient centrifugation
Find out how to isolate PBMCs from whole blood samples using density gradient centrifugation a.k.a. the Ficoll Overlay method.